logo
Plus   Neg
Share
Email

Bayer Board To Address Glyphosate Litigation; Shares Surge

The Supervisory Board of Bayer AG (BAYZF.PK,BAYRY.PK,BYR.L) has decided to establish a Supervisory Board committee to make recommendations on glyphosate litigation. Also, it has retained U.S. lawyer John Beisner to advise the Supervisory Board on glyphosate litigation. Beisner will attend the meetings of the new committee.

With regard to the current glyphosate litigation, the Supervisory Board said it recognizes the negative effect of the litigation, and plans to constructively engage in the mediation process.

Separately, shareholder Elliott welcomed the Board's decision, and revealed that he has a stake in Bayer AG. Shares of Bayer AG were up more than 7% on Thursday.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. is taking necessary precautions including Covid-19 testing for those employees returning to work at its headquarters in Silicon Valley, Bloomberg reported citing people familiar with the process. The company, which opened its main Apple Park office in May bringing back some hardware and software engineers, plans the gradual reopening of the building keeping the coronavirus safeguards. A U.S. appeals court has blocked the sales of Bayer AG's dicamba-based Xtendimax in the United States. The three-judge panel in the U.S. Court of Appeals for the Ninth Circuit ruled that the US Environmental Protection Agency (EPA) overstated the protections and substantially understated or ignored the risks related to the use of dicamba-based herbicides. Tesla Chief Executive Officer Elon Musk has called for a breakup of Amazon after the online retail giant refused to publish an upcoming book about COVID-19. Writer Alex Berenson said on Twitter that Amazon refused to publish his booklet about the coronavirus as it did not comply with the company's guidelines. Berenson is a former New York Times reporter.
Follow RTT